Key Takeaways
- Rocket Lab (RKLB) shares advanced 5.1% on Monday, peaking at $138.38 with trading volume 36% higher than usual.
- First-quarter fiscal 2026 revenue reached $200.35M, a 63.4% year-over-year increase that surpassed the $189.65M consensus.
- Deutsche Bank boosted its price target from $73 to $120; Craig Hallum upgraded the stock to Buy.
- Cantor Fitzgerald’s Andres Sheppard identified the forthcoming Neutron rocket debut as a “major catalyst” for investors.
- Wall Street consensus stands at Moderate Buy: 11 Buy ratings, 4 Hold ratings; average target price of $100.17.
Shares of Rocket Lab (RKLB) advanced 5.1% during Monday’s session, reaching an intraday peak of $138.38 before closing at $131.16. Volume registered at 32.1 million shares, representing a 36% spike compared to typical daily activity.
The upward momentum came after the aerospace company reported first-quarter fiscal 2026 results on May 7. Revenue totaled $200.35 million, exceeding Wall Street’s $189.65 million forecast and marking a 63.4% jump from the prior-year period.
Earnings per share registered at ($0.07), matching analyst projections. The company’s net margin currently sits at -26.87%, with return on equity at -11.72%.
Rocket Lab closed the quarter with a $2.2 billion backlog and reported having over $2 billion in available liquidity.
Rocket Lab described the period as another quarter of record-breaking financial results, highlighting numerous significant contract awards and the successful completion of strategic acquisitions.
Wall Street Raises Price Objectives
On May 12, Deutsche Bank increased its price objective on RKLB from $73 to $120 while reaffirming its Buy rating. The firm noted that demand across Rocket Lab’s business segments continues to accelerate.
Clear Street similarly elevated its target, adjusting from $88 to $98 with a maintained Buy stance. The analysts highlighted record first-quarter revenue that exceeded projections by 5%, driven by solid performance in both launch operations and space systems divisions.
Craig Hallum upgraded shares from Hold to Buy on May 8, establishing a $98 price objective. Citigroup confirmed its Outperform rating on the same date.
Andres Sheppard from Cantor Fitzgerald, a 5-star rated analyst, maintained his Overweight rating with a $96 target following the quarterly release. He indicated that a “major catalyst” may still lie ahead for the stock.
Neutron Launch Takes Center Stage
Sheppard highlighted Rocket Lab’s forthcoming Neutron rocket as a critical growth catalyst. Company leadership confirmed the vehicle remains on schedule for its inaugural launch during the latter part of this year.
With 87 successful launches already completed, Rocket Lab possesses a competitive advantage over emerging rivals who are still validating their launch systems, according to Sheppard.
Cantor Fitzgerald projects Rocket Lab will execute 27 launches throughout fiscal 2026 using its Electron and Haste rocket platforms.
The aerospace firm maintains launch facilities in New Zealand and the United States. Its portfolio of three rocket programs—Electron, Haste, and Neutron—addresses various segments within the space industry.
Institutional ownership of RKLB stock stands at 71.78%. Vanguard expanded its holdings by 13.4% during the fourth quarter, while Baillie Gifford increased its position by 47.2%.
Company insiders have divested 333,449 shares valued at approximately $28.3 million during the past 90 days.
The Street’s consensus recommendation is Moderate Buy, reflecting 11 Buy ratings, 4 Hold ratings, and zero Sell ratings issued over the last three months. The average analyst price target of $100.17 suggests potential downside from present levels following the stock’s recent surge.
RKLB currently trades above its 50-day moving average of $78.81 and its 200-day moving average of $70.85, both significantly below the stock’s current valuation.
